Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2003

View Archived Issues

BILS-45-BS demonstrates significant efficacy against aciclovir-resistant HSV-1

Comorbid disorders reported to reduce the response to paroxetine in OCD

Intravesical rhIL-12 in recurrent STCC of the bladder

Beneficial effects described for thymosin beta4 in septic shock

CB-300638, a thmidylate synthase inhibitor with potential as an antitumor agent

FDA approval for Crestor

Tumor necrosis therapy receives marketing approval for lung cancer in China

Phase IIIb results support use of diquafosol in dry eye

AlphaCor introduction for cornea transplant patients who reject human tissue

DakoCytomation acquires rights to H. pylori detection test

Predix and Physiome Sciences merge

BMS files IND for p38 kinase inhibitor for rheumatoid arthritis

ICN expands Kinerase license with Senetek

Q2 developments at Xoma

Angiotech: Q3 progress

NPS offers late-stage development progress report

Encysive reports on recent events

Guilford patent covers new PARP inhibitors and their use

Scientists at Sumitomo identify novel PPARdelta agonists

Takeda develops new fusion inhibitors for AIDS therapy

New hair growth-promoting agents prepared and tested at Kao

Japanese team presents new compounds with proapoptotic and cell adhesion-inhibitory activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...